Clinical Trial

The Intensive Nutritional Support in Esophageal Cancer Undergoing Neoadjuvant Therapy

Study acronym: INSECNT
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 16, 2025 (before its estimated December 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
Patients with esophageal cancer undergoing neoadjuvant therapy were selected as research subjects for nutritional risk screening and malnutrition assessment. Patients identified with nutritional risk were randomized into the standard nutrition therapy group (SNT) and the intensive nutrition therapy group (INT). The surgical rate was evaluated in both groups of patients, and the effects of nutritional support therapy on nutritional status and quality of life were investigated.
Trial Details
NCT Number NCT07067359
Lead Sponsor Sichuan University
Conditions Esophageal Cancer
Enrollment 200 participants
Start Date 2025-07-15
Primary Completion 2025-12-30 (estimated)
Study Completion 2026-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-07-16